Stay updated on DCVax-L for Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.

Latest updates to the DCVax-L for Newly Diagnosed GBM Clinical Trial page
- Check6 days agoChange DetectedThe page revision has been updated to v3.5.4, replacing the prior v3.5.3. This indicates a minor update to the page version.SummaryDifference0.0%

- Check13 days agoChange DetectedNo text changes were detected; the page content remains as previously published.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page’s revision label was updated from v3.5.2 to v3.5.3, signaling a new version of the record. This appears to be a metadata update rather than a substantive change to trial details.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded revision: v3.4.3 and removed revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to DCVax-L for Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DCVax-L for Newly Diagnosed GBM Clinical Trial page.